The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1-Benzyl-piperidin-4-yl)-4-phenyl-3,4-dihydro-1H-quinazolin-2-one; citrate ID: ALA201886
PubChem CID: 44407170
Max Phase: Preclinical
Molecular Formula: C32H35N3O8
Molecular Weight: 397.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C1Nc2ccccc2C(c2ccccc2)N1C1CCN(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C26H27N3O.C6H8O7/c30-26-27-24-14-8-7-13-23(24)25(21-11-5-2-6-12-21)29(26)22-15-17-28(18-16-22)19-20-9-3-1-4-10-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h1-14,22,25H,15-19H2,(H,27,30);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
Standard InChI Key: WCKBTFCXSLTEBC-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 46 0 0 0 0 0 0 0 0999 V2000
5.1667 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9917 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1667 -2.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1667 -0.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4042 -2.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4542 -2.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8875 -0.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2292 -2.1625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7417 -2.2750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4542 -0.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4542 -3.5125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9917 -2.8750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3417 -1.4500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6708 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6708 -1.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3875 -1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3958 -2.6917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1083 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1083 -2.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0500 -1.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 -0.2167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0417 -2.6917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7625 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0500 -0.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3875 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7667 0.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4750 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1917 0.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8208 -1.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2042 1.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8208 -2.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0958 0.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6833 0.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5000 1.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9292 1.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5333 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5333 -2.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6833 1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1000 1.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9375 2.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5042 2.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2250 2.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3875 1.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
5 2 1 0
6 3 1 0
7 4 1 0
8 5 1 0
9 6 1 0
10 4 2 0
11 6 2 0
12 5 2 0
13 1 1 0
15 14 1 0
16 15 1 0
17 14 1 0
18 19 1 0
19 17 1 0
20 15 1 0
21 26 1 0
22 14 2 0
23 20 1 0
24 20 1 0
25 16 1 0
26 24 1 0
27 23 1 0
28 21 1 0
29 18 2 0
30 28 1 0
31 19 2 0
32 25 1 0
33 25 2 0
34 30 2 0
35 30 1 0
36 29 1 0
37 31 1 0
38 33 1 0
39 32 2 0
40 35 2 0
41 34 1 0
42 41 2 0
43 39 1 0
18 16 1 0
36 37 2 0
21 27 1 0
38 43 2 0
40 42 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.52Molecular Weight (Monoisotopic): 397.2154AlogP: 5.29#Rotatable Bonds: 4Polar Surface Area: 35.58Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.78CX Basic pKa: 8.38CX LogP: 4.61CX LogD: 3.59Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -0.74
References 1. Hasegawa H, Muraoka M, Matsui K, Kojima A.. (2003) Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives., 13 (20): [PMID:14505651 ] [10.1016/s0960-894x(03)00744-3 ] 2. Hasegawa H, Muraoka M, Matsui K, Kojima A.. (2006) A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives., 16 (3): [PMID:16249082 ] [10.1016/j.bmcl.2005.10.012 ]